Phenylisopropylamine
Brand names,
Phenylisopropylamine
Analogs
Phenylisopropylamine
Brand Names Mixture
- Adderall (amphetamine + dextroamphetamine)
- Adderall XR 10mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
- Adderall XR 15mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
- Adderall XR 20mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
- Adderall XR 25mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
- Adderall XR 30mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
- Adderall XR 5mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
Phenylisopropylamine
Chemical_Formula
C9H13N
Phenylisopropylamine
RX_link
http://www.rxlist.com/cgi/generic3/adderallxr.htm
Phenylisopropylamine
fda sheet
Phenylisopropylamine
msds (material safety sheet)
Phenylisopropylamine
Synthesis Reference
U. S. Pat. 1,879,003, (1932)
Phenylisopropylamine
Molecular Weight
135.206 g/mol
Phenylisopropylamine
Melting Point
Volatizes slowly at room temperature
Phenylisopropylamine
H2O Solubility
Slightly
Phenylisopropylamine
State
Solid
Phenylisopropylamine
LogP
1.799
Phenylisopropylamine
Dosage Forms
Capsules
Phenylisopropylamine
Indication
For treatment of Attention Deficit Disorder with Hyperactivity (ADDH) and narcolepsy in children.
Phenylisopropylamine
Pharmacology
Amphetamine and dextroamphetamine, non-catechloamine sypathomimetic agents, are used in combination to treat attention-deficit hyperactivity disorder (ADHD) or narcolepsy. Adderall consists of equivalent amounts of amphetamine aspartate, amphetamine sulfate, dextroamphetamine saccharate, and dextroamphetamine sulfate.
Phenylisopropylamine
Absorption
It forms easily absorbed molecules that are highly lipid soluble
Phenylisopropylamine
side effects and Toxicity
LD50=180 mg/kg(s.c in rat). The most common presenting symptoms seen are agitation, hallucinations, suicidal behaviour, and chest pain.
Phenylisopropylamine
Patient Information
Amphetamines may impair the ability of the patient to engage in potentially hazardous activities such as operating machinery or vehicles; the patient should therefore be cautioned accordingly.
Phenylisopropylamine
Organisms Affected
Humans and other mammals